Miscarriage risk score: help or harm?
NCT ID NCT07609602
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether telling women their personalized miscarriage risk score affects their anxiety levels. 372 women under 12 weeks pregnant with a single ongoing pregnancy will be randomly assigned to either receive their risk score or not. Researchers will measure anxiety and worry at the start and after one week to see if the information is helpful or harmful.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that giving women a personalized miscarriage risk score helps them feel more informed and less anxious during early pregnancy.
- What could go wrong
- This is a small, early-stage study that only measures psychological effects, not pregnancy outcomes. The score may not reduce anxiety and could even increase worry for some women.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 372 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Have capacity to understand the study and to provide signed and dated informed consent. * Willing to comply with all study procedures and be available for the duration of the study including consenting to follow up of the pregnancy outcome by letter, phone or email according to individual preference. * Age 16 years or over * Single live ongoing intrauterine pregnancy less than 12 weeks gestation Exclusion Criteria: Women with pregnancies of unknown location, ectopic pregnancies or early pregnancy prior to an embryo being seen or an embryo without a heartbeat. * Multiple pregnancies * Those undergoing assessment or treatment for a psychological condition by a psychiatrist * Those who do not speak English or require a translator * Women who have taken part in another clinical trial in the last 3 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Early pregnancy bleeding are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.